CpG ODN (1826), TLR9 ligand (Class B) | Abeomics | Biomol.de
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
Sequence List of CpG-C ODNs | Download Table
Sequence-specific Labeling of Nucleic Acids and Proteins with Methyltransferases and Cofactor Analogues | Protocol (Translated to German)
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
Publikationen von Prof. Jeltsch | Institut für Biochemie und Technische Biochemie | Universität Stuttgart
Vaccines | Free Full-Text | Toll-Like Receptor 21 of Chicken and Duck Recognize a Broad Array of Immunostimulatory CpG-oligodeoxynucleotide Sequences
CpG ODN (1826), TLR9 ligand (Class B) | Abeomics | Biomol.de
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques | Science Advances
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 | Scientific Reports
Frontiers | Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21
Frontiers | Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
DNA methylation enables transposable element-driven genome expansion | PNAS
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 | Scientific Reports
CpG oligodeoxynucleotide - Wikipedia
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect
Development of CpG-Oligodeoxynucleotides for Effective Activation of Rabbit TLR9 Mediated Immune Responses | PLOS ONE
SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus | SpringerLink
Development of the CpG Adjuvant 1018: A Case Study | SpringerLink
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 | Scientific Reports
